Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Head & Neck 1

Conditions

Head and Neck Neoplasms 20 Squamous Cell Carcinoma of Head and Neck 11 Mouth Neoplasms 6 Lung Neoplasms 5 Head and Neck Carcinoma 5 Oropharyngeal Neoplasms 4 Laryngeal Neoplasms 4 Stomatitis 3 Xerostomia 2 Hypopharyngeal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Ulcer 1 Tonsillar Neoplasms 1 Tongue Neoplasms 1 Tobacco Use 1 Speech 1 Recurrence 1 Parotid Neoplasms 1 Parathyroid Neoplasms 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Mucositis 1 Maxillary Sinus Neoplasms 1 Lymphedema 1 Localized Head and Neck Carcinoma 1 Hyperparathyroidism, Primary 1 Hypercalcemia 1 Fibrosis 1 Esophageal Neoplasms 1

Interventions

Cisplatin 8 Radiotherapy 7 Radiation 4 Injections 3 Fibroblast Growth Factor 7 3 Radiotherapy, Intensity-Modulated 2 RRx-001 2 Propolis 2 Honey 2 Amifostine 2 pegfilgrastim 1 oxycodone-acetaminophen 1 kang-lai-te 1 golotimod 1 cyclohexaneacetic acid 1 brilacidin 1 acetaminophen, hydrocodone drug combination 1 Xylitol 1 Water 1 Vaccinium myrtillus extract 1 Traumeel S 1 Tramadol 1 Thioctic Acid 1 Therapeutics 1 Surgical Procedures, Operative 1 Sucralfate 1 Standard of Care 1 Sodium Chloride 1 Selenomethionine 1 Pain Management 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Mucositis × Standard of Care × Head & Neck × Clear all

NCT01917942 2017-07-12

RadioHum

Trans Tasman Radiation Oncology Group

Phase 3 Completed

Head & NeckOther

Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡